Advancements in treatment for rheumatoid arthritis, such as biologic drugs, have drastically improved the outlook for those with the condition. Biologics, which target specific parts of the immune system, work faster and more effectively than traditional DMARDs like methotrexate. Different types of biologics are available to treat RA, including TNF inhibitors, interleukin blockers, and JAK inhibitors. Despite the high cost of biologics, biosimilars are expected to enter the market soon, providing a more affordable treatment option. Early treatment with biologics is key to preventing joint damage and achieving positive results for individuals with RA.
Source link
Treating Rheumatoid Arthritis With a Biologic: Risks and Benefits
